IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Mescia, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 317
NA - Nord America 293
EU - Europa 275
SA - Sud America 5
AF - Africa 1
Totale 891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 288
HK - Hong Kong 128
SG - Singapore 108
IT - Italia 68
DE - Germania 48
TR - Turchia 41
RU - Federazione Russa 38
FI - Finlandia 37
IE - Irlanda 27
GB - Regno Unito 24
CN - Cina 21
ID - Indonesia 13
UA - Ucraina 6
CZ - Repubblica Ceca 5
AT - Austria 4
CA - Canada 4
NL - Olanda 4
PL - Polonia 4
JP - Giappone 3
BR - Brasile 2
CO - Colombia 2
ES - Italia 2
LT - Lituania 2
LU - Lussemburgo 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
CI - Costa d'Avorio 1
FR - Francia 1
GE - Georgia 1
KH - Cambogia 1
LV - Lettonia 1
MX - Messico 1
PE - Perù 1
SE - Svezia 1
Totale 891
Salva come PNG Salva come JPEG
Città #
Hong Kong 128
Singapore 89
Chandler 53
Istanbul 40
Helsinki 36
Dublin 27
Moscow 19
Romola 18
Jakarta 13
Nuremberg 12
Ashburn 11
Shanghai 10
Beijing 9
London 9
New York 9
Cambridge 8
Princeton 8
Wilmington 7
Fairfield 6
Frankfurt am Main 6
Los Angeles 6
Woodbridge 6
Bologna 5
Brno 5
Florence 4
Jacksonville 4
Lowicz 4
Houston 3
Kilburn 3
Allston 2
Amsterdam 2
Barcelona 2
Chiswick 2
Colorno 2
Luxembourg 2
Mantova 2
Milan 2
Modena 2
Munich 2
Ottawa 2
Pereira 2
Reston 2
Seattle 2
St Louis 2
São Paulo 2
The Bronx 2
Torino 2
Toronto 2
Verona 2
Vienna 2
Washington 2
Abidjan 1
Ann Arbor 1
Bergamo 1
Bosio 1
Brescia 1
Brussels 1
Carpenedolo 1
Changsha 1
Clifton 1
Enschede 1
Genova 1
Hounslow 1
Islington 1
Lappeenranta 1
Lima 1
Mexico City 1
Padova 1
Phnom Penh 1
Pisa 1
Riga 1
San Diego 1
Tbilisi 1
Tokyo 1
Turin 1
Viterbo 1
Wandsworth 1
Totale 628
Salva come PNG Salva come JPEG
Nome #
Cluster analysis identifies distinct pathogenetic patterns in c3 glomerulopathies/immune complex–Mediated membranoproliferative GN 81
Monoallelic pathogenic IFT140 variants are a common cause of autosomal dominant polycystic kidney disease–spectrum phenotype 48
SARS-CoV-2 infection in dialysis and kidney transplant patients: immunological and serological response 46
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity 32
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion 27
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 27
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult 26
Prevention and Therapeutic Management of Bleeding in Dialysis Patients 24
Eosinophilic granulomatosis with polyangiitis present and future 24
Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia 24
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19 23
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination 23
Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission 23
The impact of hypoxia on B cells in COVID-19 23
Kidney transplantation from a donor with acute kidney injury: An unexpected outcome 22
An Initial Low-Dose Etelcalcetide Dosing Strategy in Hemodialysis Patients With Moderate Secondary Hyperparathyroidism is Effective and Cost-Saving 22
Effective control of sars-cov-2 transmission between healthcare workers during a period of diminished community prevalence of covid-19 22
Analysis of the B cell receptor repertoire in six immune-mediated diseases 21
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant 21
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 21
Sustained post-rituximab B cell depletion is common in ANCA-associated Vasculitis and affected by sex and renal function 21
Impact of Acute Kidney Injury and CKD on Adverse Outcomes in Critically Ill Septic Patients 19
A thermostable, closed SARS-CoV-2 spike protein trimer 19
Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease 19
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study 18
SARS-CoV-2 evolution during treatment of chronic infection 18
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report 16
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection 16
STEC-HUS, atypical HUS and TTP are all diseases of complement activation 16
Single-cell multi-omics analysis of the immune response in COVID-19 15
The place of cyclical therapy for the treatment of membranous nephropathy in the era of rituximab 14
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 14
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 14
SARS-CoV-2 spike N-terminal domain modulates TMPRSS2-dependent viral entry and fusogenicity 13
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 12
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies 11
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 10
Clinical Significance of the Cystic Phenotype in Alport Syndrome 10
Treatment goals in ANCA-associated vasculitis: defining success in a new era 9
Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19 9
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups 8
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity 7
Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis 7
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 7
Proinflammatory cytokines driving cardiotoxicity in COVID-19 5
sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID 5
Totale 912
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.681
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 1 6 7 6 2 3
2020/202125 0 4 0 1 6 2 2 1 3 1 5 0
2021/202223 1 2 0 0 0 1 0 0 6 3 3 7
2022/2023174 7 0 5 18 5 59 0 21 37 2 10 10
2023/2024345 15 16 8 40 13 11 10 49 100 7 14 62
2024/2025320 4 10 28 109 73 90 6 0 0 0 0 0
Totale 912